Progress
Scope
Timeline of events
Measures in amended Executive Order 14256 on duty-free de minimis treatment for low-value imports increasing ad valorem rate and per-item duty enter into force
On 2 May 2025, the measures in Executive Order 14256, as amended by the Executive Order on the amendment to reciprocal tariffs and updated duties as applied to low-value imports from the People’s Republic of China, enter into force. The ad valorem r…
- AMENDMENT TO RECIPROCAL TARIFFS AND UPDATED DUTIES AS APPLIED TO LOW-VALUE IMPORTS FROM THE PEOPLE’S REPUBLIC OF CHINA, US White House (Official)
President signed Order 14256 amending Executive Order 14195 revoking duty-free de minimis treatment for low-value imports
On 2 April 2025, the President of the United States signed Executive Order 14256 ending duty-free de minimis treatment for low-value imports from China and Hong Kong. The Executive order specifies that it aims to address the illicit flow of syntheti…
- Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China as Applied to Low-Value Imports, United States White House (Official)
President signed order postponing implementation of Executive Order 14195 revoking duty-free de minimis treatment under customs duties
On 5 February 2025, the President signed an order postponing the implementation of Executive Order 14195 revoking duty-free de minimis treatment under customs duties. The order specifies that the duty-free de minimis treatment under custom duties ap…
- AMENDMENT TO DUTIES ADDRESSING THE SYNTHETIC OPIOID SUPPLY CHAIN IN THE PEOPLE’S REPUBLIC OF CHINA, The White House (Official)
President signed Executive Order 14195 addressing duty-free de minimis treatment under customs duties
On 1 February 2025, the President signed Executive Order 14195 on Imposing Duties To Address the Synthetic Opioid Supply Chain in the People's Republic of China, which includes provisions addressing duty-free de minimis treatment under customs dutie…
- Imposing Duties to Address the Synthetic Opioid Supply Chain in the People’s Republic of China, The White House (Official)